Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo

Por Andersson, Y, Engebraaten, O, Fodstad, Ø
Publicado em 2009

Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and in...

Por Engebraaten, O, Hjortland, GO, Martinsen, M, Halvorsen, T, Fodstad, Ø, Ree, AH
Publicado no Breast Cancer Res (2005)

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin

Por Andersson, Y, Engebraaten, O, Juell, S, Aamdal, S, Brunsvig, P, Fodstad, Ø, Dueland, S
Publicado no Br J Cancer (2015)

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.

Por Maelandsmo, G. M., Flørenes, V. A., Hovig, E., Oyjord, T., Engebraaten, O., Holm, R., Børresen, A. L., Fodstad, O.
Publicado em 1996

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

Por Fangberget, A., Nilsen, L. B., Hole, K. H., Holmen, M. M., Engebraaten, O., Naume, B., Smith, H.-J., Olsen, D. R., Seierstad, T.
Publicado em 2010